Portfolio Design Labs’s Vertex Pharmaceuticals VRTX Stock Holding History

Portfolio Design Labs’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$592K	Buy	1,192 +1	+0.1%	+$443	0.1%	146
2026 Q1	$532K	Sell	1,191 -14	-1%	-$6.53K	0.09%	159
2025 Q4	$546K	Buy	1,205 +316	+36%	+$136K	0.09%	155
2025 Q3	$348K	Buy	889 +9	+1%	+$3.76K	0.06%	162
2025 Q2	$392K	Sell	880 -856	-49%	-$394K	0.08%	110
2025 Q1	$842K	Sell	1,736 -5,390	-76%	-$2.51M	0.17%	101
2024 Q4	$2.87M	Buy	7,126 +2,547	+56%	+$1.18M	0.59%	48
2024 Q3	$2.13M	Buy	4,579 +2,526	+123%	+$1.21M	0.59%	48
2024 Q2	$962K	Sell	2,053 -510	-20%	-$221K	0.3%	81
2024 Q1	$1.07M	Sell	2,563 -7,365	-74%	-$3.11M	0.36%	82
2023 Q4	$4.04M	Buy	+9,928	New	+$3.67M	1.53%	23

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Portfolio Design Labs's VRTX Position: Q2 2026 in Review

Portfolio Design Labs increased its Vertex Pharmaceuticals (VRTX) stake by 0.08% in Q2 2026, buying an estimated $443 and bringing the position to 1,192 shares worth $592K. The position accounts for 0.1% of the portfolio, ranked #146.

Portfolio Design Labs first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.04M in Q4 2023. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Portfolio Design Labs held 1,192 shares of Vertex Pharmaceuticals worth $592K as of Q2 2026.
Portfolio Design Labs bought 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
Vertex Pharmaceuticals made up 0.1% of Portfolio Design Labs's portfolio in Q2 2026, its #146 holding.
Portfolio Design Labs first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
Portfolio Design Labs's Vertex Pharmaceuticals position peaked at $4.04M in Q4 2023.
1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.